Angiodynamics (ANGO) Income from Continuing Operations (2010 - 2026)
Angiodynamics (ANGO) posted Income from Continuing Operations of 11405000.0 for Q2 2026, down 41.08% on a QoQ basis from 8084000.0 in Q1 2026, and down 88.51% year-over-year from 99280935.25 in Q2 2025.
Angiodynamics (ANGO) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Angiodynamics' Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 11405000.0 for Q2 2026.
- Quarterly Income from Continuing Operations fell 88.51% year-over-year to 11405000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was 36742000.0 (down 8.09% YoY) and the FY2026 annual result came in at 36742000.0, down 8.09% from the prior year.
- Income from Continuing Operations was 11405000.0 for Q2 2026 at Angiodynamics, down from 8084000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 45884000.0 in Q3 2023 and bottomed at 187736000.0 in Q1 2024.
- A 5-year average of 17708333.33 and a median of 10111500.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations jumped 452.85% — and 2024, when it sank 1879.29%.
- Angiodynamics' Income from Continuing Operations stood at 8486000.0 in 2022, then plunged by 242.3% to 29048000.0 in 2023, then soared by 63.03% to 10738000.0 in 2024, then surged by 40.86% to 6350000.0 in 2025, then slumped by 79.61% to 11405000.0 in 2026.
- Business Quant data shows ANGO's Income from Continuing Operations at 11405000.0 in Q2 2026, 8084000.0 in Q1 2026, and 6350000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn | -11.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -11.41 Mn |
| Feb 28, 2026 | -8.08 Mn |
| Nov 30, 2025 | -6.35 Mn |
| Aug 31, 2025 | -10.90 Mn |
| May 31, 2025 | -6.05 Mn |
| Feb 28, 2025 | -4.41 Mn |
| Nov 30, 2024 | -10.74 Mn |
| Aug 31, 2024 | -12.80 Mn |
| May 31, 2024 | -13.45 Mn |
| Feb 29, 2024 | -187.74 Mn |
| Nov 30, 2023 | -29.05 Mn |
| Aug 31, 2023 | 45.88 Mn |
| May 31, 2023 | -21.47 Mn |
| Feb 28, 2023 | -9.49 Mn |
| Nov 30, 2022 | -8.49 Mn |
| Aug 31, 2022 | -13.00 Mn |
| May 31, 2022 | -6.27 Mn |
| Feb 28, 2022 | -4.96 Mn |
| Nov 30, 2021 | -8.35 Mn |
| Aug 31, 2021 | -6.97 Mn |